The new initiative ofASST of Cremona sees as main future mothers are the protagonists, in fact, it is a screening process capable of identifying the problems present in the fetus within a few weeks. The second video that tells the “birth journey” is online at the hospital Cremona.
Prenatal screening in the Lombardy region
This week is dedicated to prenatal screening, it is a birth process that affects all pregnant women from the 12th week, as foreseen by the regional programs. This path is therefore addressed not only to pregnant women residing in the Cremona areabut all the women present within the Lombardy Region.
The service offered by the Cremona Hospital offers the possibility of monitor pregnancyalso going to carry out some non-invasive tests that allow you to understand understand the risk of having one of the main chromosomopathiesi.e. Down syndrome, trisomy 13 and others.
Doctor Deborah Mammoliti
There Doctor Debora Mammoliti, Gynecologist and responsible forPrenatal diagnosis clinic of the Cremona Hospital, explains the entire birth process through a dedicated video.
“Our service offers the possibility of carrying out an examination of non-invasive screening called combined test. The test consists of an ultrasound and a blood sample, the result of which will help understand the risk of having one of the main chromosomopathies, i.e. Down syndrome, trisomy 13 and trisomy 18 or sex chromosome abnormalities. The combined test it is performed from the 11th to the 13th week of pregnancy with ticket and reservation via CUP.”
“In case of a positive screening result, according to regional legislation, for the woman the possibility of carrying out a further test is foreseen (non-invasive) which involves a blood sample in order to analyze fetal DNA circulating in maternal blood. Also in this case it is a screening test, i.e. probabilistic. The only definitive diagnosis is obtained through an invasive test, in this case amniocentesis.”
“It is important to dispel the myth ofamniocentesis as a dangerous test. This is an examination carried out around the 16th week: it is invasive, but with a very low risk of fetal loss. It is the only exam that allows a certainty diagnosis regarding chromosomal pathologies.”
